Related Experiment Video

Updated: Jul 28, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.1K

Correction to: Letter to the Editor-Recent advances in Lynch syndrome

Pål Møller1, Julian Sampson2, Mev Dominguez-Valentin3

  • 1Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. moller.pal@gmail.com.

Familial Cancer
|April 1, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 28, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.1K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

The Tumor Microenvironment Score and Its Subsite-Specific Relevance in Colon Cancer.

The American journal of surgical pathology·2026

Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.

Oncogene·2026

Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022.

Gut·2026

Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial.

The lancet. Gastroenterology & hepatology·2026

Tumor-Infiltrating Basophils Are Associated With Improved Prognosis in Colorectal Cancer.

Laboratory investigation; a journal of technical methods and pathology·2026

Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

The Journal of pathology·2026

Opportunities to improve detection of genetic predisposition for ovarian cancer applying the Tumor-First workflow.

Familial cancer·2026

Routes to colorectal cancer in Lynch syndrome: a decade of molecular and clinical insights converging on Schrödinger's cat.

Familial cancer·2026

Mainstream and fast-track genetic testing in pancreatic cancer patients and its impact on treatment: our experience in a tertiary hospital in Spain.

Familial cancer·2026

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey.

Familial cancer·2026

Impact of updated NCCN guidelines on clinical management and risk communication for CHEK2 p.I157T carriers in breast cancer.

Familial cancer·2026

Clinical and surveillance outcomes of the TP53 c.1000G > C (p.Gly334Arg) variant.

Familial cancer·2026

Confirmation of HLA-C*07:24:02 in a Brazilian Individual by Next-Generation Sequencing.

HLA·2026

Latent profile analysis of eHealth literacy and its sociodemographic correlates: a cross-sectional study.

Frontiers in public health·2026

Correction: 'She lifted me up': kinship construction in human-AI resilient communication among Chinese users.

Frontiers in psychology·2026

Erratum: Li X, Tang Y, Chen C, Wang P, Shen Y. CHEST Pulmonary. 2023;1(2):100011.

CHEST pulmonary·2026

Clinical significance and outcomes of left-sided gallbladder for cholecystectomy: A retrospective cohort study based on 12-year single-center experience.

Annals of hepato-biliary-pancreatic surgery·2026

Lung transplantation in 2025: a narrative review of progress, challenges, and the road ahead.

Journal of thoracic disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us